Crescent Biopharma, Inc. CBIO
14.87 USD +0.95 (+6.82%)
Nov 11, 2026, 3:51 PM EST
13.86 Day range 15.00
8.72 52-week range 27.41
- YTD
- +25.38%
- 1 year
- +12.23%
CBIO revenue history
Revenue is income from the company’s ordinary business activities.
10,844,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Some periods have no fiscal period label and are omitted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 10,844,000 | 10,844,000 | Not meaningful |
| FY 2024 | 2024-12-31 | 0 | -10,000 | -100.00% |
| FY 2023 | 2023-12-31 | 10,000 | -65,000 | -86.67% |
| FY 2022 | 2022-12-31 | 75,000 | -1,084,767 | -93.53% |
| FY 2021 | 2021-12-31 | 1,159,767 | -9,003,168 | -88.59% |
| FY 2020 | 2020-12-31 | 10,162,935 | 10,162,935 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | -18,500 | -100.00% |
| FY 2016 | 2016-12-31 | 18,500 | -20,052,250 | -99.91% |
| FY 2015 | 2015-12-31 | 20,070,750 | 5,043,746 | 33.56% |
| FY 2014 | 2014-12-31 | 15,027,004 | 11,034,355 | 276.37% |
| FY 2013 | 2013-12-31 | 3,992,649 | -11,264,702 | -73.83% |
| FY 2012 | 2012-12-31 | 15,257,351 | 11,443,438 | 300.04% |
| FY 2011 | 2011-12-31 | 3,813,913 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-07-31T06:02:20.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.